INTRODUCTION
Mental retardation represents a deficiency in intelligence, as measured by IQ, with limited adaptive behavior that is normally reflected in maturation, learn ing, or social adjustment (American Psychiatric Association 1987) . Approxi mately 1 to 3% of the population, depending upon definitions of adaptive behavior, is mentally retarded (Popper 1988) . The etiologies and determinants of mental retardation are diverse and include socioeconomic influences leading to extreme malnutrition and/or inadequate prenatal care; toxic insults, such as that leading to fetal alcohol syndrome; trauma and infection; and genetic factors (Popper 1988) . At least 300 genetic disorders include mental retardation as part of the phenotype, and genetic components are considered important influences on related disorders such as attention deficit disorder and learning disability (Smith et al 1983 , Biederman et al 1987 , McKusick et al 1992 .
Since the early twentieth century a male predominance at all levels of mental retardation, ranging from 1.5 to 3 times the incidence in females, has been acknowledged (Penrose 1938) . Although a variety of explanations have been put forth, including the probable ascertainment bias of mentally retarded males being more frequently institutionalized because of uncontrollable or violent behavior, there is good reason to believe X-linked loci contribute significantly to this gender inequity (Opitz 1986) . Perhaps as many as 95 genes have been tentatively assigned to the X chromosome where mutations lead to mental retardation as at least part of the phenotype (Schwartz 1993). As the vast majority of these mutations appear recessive, females, protected by an addi tional X chromosome, are rarely affected, and hence this leads to the excess male mental retardates. However, most of these disorders are exceedingly rare, and as single loci, none would be expected to appear frequently in the popu lation. Thus, an aggregate of all X-linked mutations involving mental retarda tion appeared responsible for gender differences until a single locus, that responsible for fragile X syndrome, became recognized as a clinical entity that eventually would account for nearly half of the male predominance of mental retardation (Opitz & Sutherland 1984) .
HISTORICAL AND CLINICAL ASPECTS
Fragile X syndrome, an X-linked dominant disorder with reduced penetrance, is the most frequent form of familial mental retardation, with a prevalence of 1 in 1500 males and 1 in 2500 females (Gustavson et al 1986 . It is the single most common etiology of X-linked mental retarda tion (Neri et al 1992 , Brown & Jenkins 1992 , and ranks second only to Down's syndrome, which is most often sporadic, as the most frequent genetic cause of mental retardation overall. First described by Martin & Bell (Martin & Bell 1943) , the syndrome cosegregates with a marker X chromosome that is observed cytogenetically as a nonstaining constriction in the long arm of man & Sobensky 1989). Additionally, because the phenotype of fragile X syndrome is quite pleiotropic and difficult to diagnose de novo prior to puberty, detailed checklists involving precise anthropometric measurements have been devised (Butler et al 1991a , Butler et al 1991b , Butler et al 1992 .
INHERITANCE PATTERN
The inheritance pattern of fragile X syndrome is both complex and unusual for a sex-linked Mendelian trait. Although the inclusion of affected heterozy gous females as well as hemizygous males would suggest an X-linked domi nant mode of inheritance, the occurrence of apparently unaffected males who carry the fragile X chromosome has been well documented (Martin & Bell 1943 , Dunn et al 1963 , Howard-Peebles & Friedman 1985 , Froster-Iskenius et al 1986 . In analyses of a total of 206 fragile X pedigrees by both classical and complex segregation analyses, Sherman et al (1984 Sherman et al ( , 1985 reported a 20% deficit in affected males in the absence of evidence of any sporadic cases, a finding best explained by reduced penetrance in males of 80%. Given the fact that affected males rarely reproduced, these unusual non penetrant carrier males were termed transmitting males because they passed the fragile X chromosome to all of their obligate carrier daughters. Interestingly, nonpenetrant transmit ting males were also cytogenetically negative for fragile site expression in lymphocytes (Howard-Peebles & Friedman 1985, Froster-Iskenius et aI1986). Penetrance of mental impairment in females was also found to be reduced, with an overall penetrance of 35%, in the study by Sherman et al (1984) , and disease expression was again found to be in direct correlation with cytogenetic expression of the fragile site. Thus, a model of an X-linked dominant gene with reduced penetrance was imposed (Sherman et al 1984 (Sherman et al , 1985 . Sherman et al (1984 Sherman et al ( , 1985 made a most peculiar observation that the risk of mental impairment associated with fragile X syndrome was a function of one's position within the pedigree. As mentioned, carrier males are both nonpenetrant and cytogenetically negative for fragile X syndrome. Interest ingly, Sherman et al (1984 Sherman et al ( , 1985 found that the risk of mental impairment in obligate carrier daughters of carrier males approached 0%. Siblings of these males were also at relatively low risks of 9% and 5% in males and females, respectively. Offspring of normal carrier females, however, incurred risks of 38% (males) and 16% (females) for mental impairment, which corresponded to penetrances of 76% and 32%, while offspring of mentally impaired carrier females displayed penetrances of 100% (males) and 56% (females). Thus, disease expression was dependent upon passage of the fragile X through a female, which led some to hypothesize that a premutation in carrier males causing the fragile X chromosome to be more susceptible to alteration in female gametes might account for this observation (Pembrey et al 1985) . This odd pattern of increasing risk with vertical transcention through a pedigree, referred to as the Sherman paradox, was unique in human genetics, and it was only after the molecular basis of fragile X syndrome was elucidated that this peculiar pattern of inheritance was fully understood.
IDENTIFICATION OF THE FRAGILE X MUTATION
In 1991, the combined approaches of genetic mapping, physical mapping, and somatic cell genetics culminated in the positional cloning of the fragile X locus and the identification of the mutation responsible for fragile X syndrome. Prior to this time, the fragile X disorder had been mapped genetically through linkage analysis to the same interval as the Xq27 fragile site between the factor VIII (12 cM distal) and factor IX (5 cM proximal) loci, which narrowed the region of interest to approximately 20 megabases (Goodfellow et al 1985 , Oberle et al 1986 . Also localized to the region surrounding the fragile site were the enzymes HPRT (Xq26) (Pai et a11980) and G6PD (Xq28) (Filippi et aI1983) . By using rodent cells deficient for both of these enzymes, Warren and cowork ers (Warren et al 1987 , Warren et al 1990 successfully constructed somatic cell hybrids containing either exclusively proximal or exclusively distal por tions of the human fragile X chromosome. They did this by selection either for or against the human HPRT enzyme activity followed by histochemical staining for G6PD activity. Because it had previously been shown that the fragile X site was cytogenetically expressed in hybrid cells, chromosomal breakage at or near the fragile site was expected for most of the hybrids (Warren & Davidson 1984) . This was confirmed through hybridization of known proximal and distal X chromosome markers to the obtained hybrids (Warren et aI1990) . The availability of proximal and distal hybrids, as well as other X-breakpoint hybrids, allowed a number of new polymorphic loci to be mapped relative to the fragile site, which narrowed the gap to within 3 megabases (Suthers et al 1990 , Hirst et al 1991 , Suthers et al 1991 , Rousseau et al 1991b .
The newly identified battery of DNA markers bracketing the fragile X locus allowed isolation of yeast artificial chromosomes (YACs) with inserts spanning the fragile X hybrid breakpoints (Dietrich et al 1991 , Verkerk et al 1991 , Kremer et al 1991b . Two groups independently identified an aberrantly methylated CpG island within this region of DNA in fragile X patients. Because of the absence of normal cleavage by methylation-sensitive enzymes in fragile X cells, a band of anomalous mobility on pulsed-field gel electrophoresis were used to identify the abnormal CpG island (Bell et al 1991 . Oberle et al (1991) identified a 9-kb DNA segment from the Y AC 209G4 that contained the CpG island hypermethy lated in fragile X patients and that detected an apparent insertion in fragile X patients on Southern blots. Yu et al (1991) and Verkerk et al (1991) concurrently yet independently identified a single restriction fragment of approximately 5 kb that contained both the proximal and distal fragile X hybrid breakpoints and also detected length variation in fragile X patients on Southern blots. Kremer et al (199 1a) further localized this instability to a single 1.0-kb Pst I fragment, pfxa2, that was sequenced and found to contain an unusual CGG trinucleotide repeat of 43 copies. By using the polymerase chain reaction (PCR) and primers flanking the repeat, Kremer et al (1991 a) mapped the region of instability in pfxa2 to within the CGG trinucleotide repeat itself, thereby suggesting that the length variation observed in fragile X patients could result from length variation within the trinucleotide repeat. The translocation breakpoints of various hybrids were also mapped to within the CGG repeat, thus colocalizing the fragile site and the fragile X mutation to this novel trinucleotide repeat (Kremer et aI199 1a).
In order to identify expressed sequences in the fragile X breakpoint cluster region, four cosmid subclones of the YAC 209G4, which spanned the region encompassing the erroneously methylated CpG island, were used as probes against a eDNA library from human fetal brain (Verkerk et al 1991) . Two cDNA clones, BC22 and BCn, comprising a contig of 3765 nucleotides, were identified and the DNA sequence of each was obtained. Analysis of this sequence revealed a single major open reading frame that remained open at the 5' end and encoded a predicted polypeptide of 657 amino acids. The CGG repeat potentially displaying length variation in fragile X patients was con tained within the 5' portion of the open reading frame where it was initially thought to encode an uninterrupted stretch of 30 arginine residues. However, later studies demonstrate that the CGG repeat is confined to the 5' untranslated region and is, therefore, not translated (Ashley et a1 1993a) (see below). Upon northern analysis, a 4.8-kb transcript was detected in RNA from human brain and placenta, which suggested that approximately 1 kb of sequence remained to be determined. A zoo blot containing genomic DNA from a number of eukaryotes, including lower organisms such as nematode and yeast, displayed band(s) in lanes of all organisms except Drosophila when probed with BC22 under high stringency, thus indicating strong evolutionary conservation of this gene, referred to as FMRl (fragile X mental retardation 1), and implying functional importance of its protein product, FMRP. Initial data base searches at both the nucleotide and amino acid levels, however, produced no significant homologies with any previously reported sequences and provided no immedi ate clues as to the normal function of this predicted protein (see below).
FRAGILE X TRINUCLEOTIDE REPEAT EXPANSION
The delimitation of the region of DNA instability to within the CGG repeat suggested the possibility that length variation observed in fragile X carriers might result from the inherent instability of this reiterated trinucleotide repeat, which would be reminiscent of other tandemly repeated sequences such as the highly polymorphic dinucleotide repeats (Weber 1990) . Indeed, analysis of the eGG repeat of FMRl across normal populations revealed that it was highly polymorphic, with repeat sizes ranging from 6-54 triplets and a mode of 30 , Brown et al 1993 , Jacobs et al 1993 , Snow et al 1993 . In analysis of repeat sizes in fragile X pedigrees, Fu et al (1991) discovered that individuals nonpenetrant for fragile X syndrome, carrier males and their obli gate carrier daughters, displayed eGG repeat lengths ranging from 54-200 repeats, whereas affected individuals exhibited repeat sizes in excess of 200 and often greater than 1000 repeats. This finding was in agreement with the previous reports of apparently smaller insertions in carriers and larger inser tions in affected individuals (Oberle et al 1991 , Yu et al 1991 , Kremer et al 1991a , which Oberle et al (1991) referred to as premutations and full muta tions, respectively, in order to relate the size of the insertion with penetrance of the disease. This correlation between repeat size and penetrance not only allowed resolution of the Sherman paradox , but it also paved the way toward identification of other trinucleotide repeat expansion mutations by substantiating earlier claims (Harper 1989 ) that diseases displaying genetic anticipation, increasing severity, or decreasing age of onset of disease from one generation to the next might share a common form of mutation.
In addition to establishing an association between repeat size and penetrance for fragile X syndrome, studies of the repeat length of FMRl also aided in defining the boundaries of meiotic instability. In the study by Fu et al (1991) , all FMRl eGG repeats of 54 and greater displayed meiotic instability, and smearing of the full mutation bands on Southern blots suggested mitotic instability as well. In a recent analysis of 116 families referred for fragile X testing, a FMRl eGG repeat of 51 was shown to be meiotically stable through five generations, whereas a repeat of 57 displayed meiotic instability in the next generation (Snow et al 1993) . Also in this study, a eGG repeat of only 61 in a carrier female expanded into the full mutation range in the following generation. However, another premutation allele of 90 in a different carrier female only expanded to 115 upon transmission to her offspring. Therefore, repeats of 54 and above clearly display meiotic instability and should be considered premutations; however, the expansion of premutation alleles into the full mutation range must be dependent upon other factors yet to be identified.
METHYLATION OF THE FMRl GENE
In addition to trinucleotide repeat expansion in fragile X patients, abnormal methylation of a CpG island located 250 base pairs upstream of the CGG repeat of FMRl was also found in individuals expressing the fragile X phe-notype (Bell et al 1991 , Oberle et al 1991 , Vincent et al 1991 . Like expansion of the repeat, the extent of CpG-island methylation is directly correlated with disease expression because carrier males, which are unaffected, display unmethylated CpG islands. Individuals with the full mu tation, however, have fully methylated CpG islands (Oberle et al 1991) . Un affected carrier females display methylation only on the inactive X chrom osome, while affected females tend to be skewed toward excess methylation (> 50%), although this is not always the case (Oberle et al 1991) . The CGG repeat, which is itself rich in CpG dinucleotides, is also fully methylated in affected individuals with full mutations or at normal repeat copy number on the inactive X (Hansen et al 1992 , Hornstra et al 1993 . The identification of abnormal methylation associated with fragile X syndrome is in agreement with Laird's (1987) hypothesis, which states that fragile X syndrome results from persistence of an imprint that is due to failure of erasure of X inactivation in a carrier female.
Methylation of the CpG island adjacent to the FMRI gene correlates with transcriptional silencing of FMRI and expression of the fragile X phenotype. In a study by Pieretti et al (1991) , 16 of 20 affected males with expanded ".
repeats in the full mutation range displayed fully methylated CpG islands and produced no FMRI transcript. Of the four affected males with FMRI expres sion, three were identified as mosaics for fully methylated full mutations and unmethylated premutations, and one was a methylation mosaic with a partially unmethylated full mutation. In a prenatal diagnosis of an affected fetus with a full mutation, Sutcliffe et al (1992) reported an absence of methylation in chorionic villus samples that correlated with normal levels of FMRI expres sion, while in fetal tissue a fully methylated CpG island was found but not FMRI message. Recently, four carrier males with repeat sizes between 200 and 400 but with unmethylated CpG islands and repeats were found to be intellectually and physically normal by observation (Loesch et aI1993). Con versely, two males exhibiting partially methylated CpG islands and CGG repeats between 200 and 300 copies also displayed mild clinical and physical manifestations of fragile X syndrome (McConkie-Rosell et al 1993) .
Although many carrier females have pre mutation alleles, a significant pro portion of the normal carrier females carry full mutations with expansions well beyond 200 repeats as well as the abnormal methylation of the FMRI gene. Rousseau et al (1991a) demonstrated that approximately half (53%) of women with full mutations are penetrant with IQ levels in the borderline and mentally retarded range. The other half presumably escape the effect of the full mutation because of X inactivation (lyonization) patterns. However, Taylor et al (1994) showed that the pattern of X inactivation, i.e the proportion of fragile X chromosomes active versus inactive, in peripheral lymphocytes of full mutation females was not a predictor of intellectual function. Thus, it is most reasonable to conclude that the protein encoded by FMRI is cell autonomous and that the proportion of cells in key regions of the brain with the fragile X chromosome in the active state (but still not expressing FMRI because of the abnormal methylation) are responsible for penetrance in females.
Thus, the absence or reduction of FMRI expression as a function of meth ylation status of the upstream epG island and the eGG repeat is thought to be the basis for fragile X syndrome. The fact that at least four fragile X patients lacking repeat expansion but possessing other mutations of the FMRI gene itself, three large deletions and one point mutation, have been identified sup ports this hypothesis (Gideon et al 1992 , Wohrle et al 1992 , De Boune et al 1993 . The role of repeat expansion in abnormal methyl ation, or vice versa, remains to be determined.
DETECTION OF THE FRAGILE X MUTATION
Both the expansion of the eGG repeat and the abnormal methylation of the FMRI gene are important diagnostic indicators. Methods have been developed to assess these mutational parameters in patients (reviewed by Warren & Nelson 1994). Detection can employ either Southern blotting (Figure 2a) or the polymerase chain reaction (Figure 2b ). Southern blotting most commonly utilizes the digestion of genomic DNA with EcoR I and the methylation sensitive enzyme BssH II or Eag I. EcoR I digestion liberates a 5.2-kb fragment containing the promoter and first exon of FMRl, which includes the eGG repeat. Double digestion with BssH II or Eag I cleaves normal male DNA into 2.4-kb and 2.8-kb fragments; the latter fragment contains the trinucleotide repeat. The active X chromosome of normal females also displays this pattern, but the inactive normal X in a female is methylated, as is common for many X-linked loci, and is resistant to BssH II or Eag I digestion. Thus, normal females exhibit three bands as shown in lane two of Figure 2a .
Premutation alleles exhibit a shift in the 2.8-kb band to a slightly higher molecular weight that reflects the increase in the CGO repeat to the 54-230 repeat range. Full mutations display a large, somewhat diffuse band that is generally not cleaved by BssH II or Eag I. These bands reveal the expansion of the eGG repeat into the range of many hundreds of triplets as well as the abnormal methylation of the FMRI gene. Females with full mutations display a similar pattern superimposed upon that of the normal X (in both the active and inactive states).
Analysis by peR has allowed a much more precise estimation of repeat length, particularly in normal and premutation alleles (Fu et aI1991) . However, amplification of full mutations is difficult, though not impossible (Pergolizzi et al 1992) . As shown in Figure 2b , PCR amplification of the eGG repeat by using flanking primers of unique sequence demonstrates the remarkable insta- bility of the premutation alleles, where siblings often have alleles unique from one another as well as distinct from the parent. Analysis by peR is useful for defining accurate premutation repeat lengths and for demonstrating instability, which may be of some utility in genetic counseling (Warren & Nelson 1994) , and is useful in situations where limited DNA is a constraint.
OTHER TRINUCLEOTIDE REPEAT EXPANSION DISEASES
Since the emergence of the trinucleotide repeat expansion mutation responsible for fragile X syndrome, six other diseases caused by trinucleotide expansions spinal and cerebellar ataxia type 1 (SCA1) (Orr et al 199 3) ; FraX E mental retardation (Knight et al 1993) ; and dentatorubral pallidoluysian atrophy (DPA) (Koide et a1 1994, Nagafuchi et aI1994). Interestingly, all trinucleotide repeat diseases described thus far are neurologic diseases, although there is currently no good hypothesis to account for this pattern. Similarities between the trinucleotide repeats of these diseases include that they are all normally poly morphic, GC-rich, and expressed sequences, while dif ferences include the exact nucleotide content of the repeat and the location of the repeats within the various messages (Richards & Sutherland 1992 ). In the majority of these diseases (HD, SBMA, DPA, and probably SCAl), an unstable CAG repeat within the coding region of the respective genes undergoes expansion, which produces an amplified polyglutamine tract in the nascent protein. In the case of X-linked SBMA, Warren & Nelson (199 3) have suggested that the expan sion of the poly glutamine tract in the androgen receptor must constitute a gain of function, perhaps through allowing the receptor to interact with promoters that it does not normally recognize, because the absence of manifestations of testicular feminization make it unlikely that the receptor is nonfunctional. Although the function of the gene products in HD and SCAI are currently unknown, the dominant inheritance pattern of these autosomally inherited disorders argues that expansion of the polyglutamine tract in these two diseases will constitute a gain-of-function as well. In myotonic dystrophy, a CTG repeat in the 3' untranslated region (UTR) of the myotonin protein kinase gene is enlarged, which results in altered message stability and aberrant intracellular signaling due to abnormal dosage of this protein kinase (Fu et Of all of these repeat expansion mutations, only the repeats of DM and fragile X syndrome, which are within untranslated regions, have full mutations with repeat expansions exceeding several hundred copies. Repeat expansions of the other diseases are usually 2-4 ti mes normal, and maxi mu m repeat sizes rarely exceed 100 copies. This implies that the mechanis m of expansion of fragile X syndro me and myotonic dystrophy could be similar, although it is puzzling that DM does not display the parent-of-origin requirement for expan sion observed in fragile X syndrome. However, reductions in trinucleotide repeat sizes, which are almost never seen in fragile X syndrome, are often seen in paternal DM alleles (Reyniers et al 1993) . Nevertheless, given the fact that the full mutations of DM or fragile X are not amenable to cloning, the other trinucleotide diseases with more subtle trinucleotide expansions will most likely be more infor mative with regard to the mechanis m of trinucleotide instability.
MECHANISM OF THE FRAGILE X REPEAT EXPANSION
The molecular mechanis m of trinucleotide repeat expansion still re mains an enigma, although recent advances in the fragile X field have been enlightening. In previous segregation analyses of over 200 fragile X pedigrees, no sponta neous mutations in fe male ga metes causing fragile X syndrome were identified (Sherman et a11984, 1985) . Given the fact that fragile X alleles are constantly being re moved from the gene pool because of reduced fitness in affected individuals, Sherman et al (1984 Sherman et al ( , 1985 predicted an extraordinarily high mutation rate in male gametes, on the order of 7.2 x 10-4, to account for the high prevalence of fragile X syndro me within the population. However, sub sequent analyses of fragile X pedigrees have failed to detect any new mutations producing fragile X syndrome (Jacobs et al 1986 , Rousseau et al 1991a , Yu et al 1992 . Consistent with the absence of new mutations, Smits et al (1993) recently found that five fragile X males related through co mmon ancestors from the eighteenth century were all concordant for the same allele at the DXS548 locus, a polymorphic marker locus located 15 0 kb proximal to FMRl (Riggins et al 19 92). This finding attests to the very old nature of the fragile X mutation in this family and suggests the possibility of linkage disequilibrium in the region enco mpassing the fragile X locus. Haplo type analyses of markers flanking the fragile X locus have, in fact, revealed significant linkage disequilibrium between fragile X syndrome and certain haplotypes, which indicates that a small group of founder chromosomes, per haps as few as six, might account for the vast majority of fragile X mutations observed today , Oudet et al 1993 . The observation of linkage disequilibrium in the region of the fragile X locus is reminiscent of the situation in individuals with myotonic dystrophy (DM), the gene of which is in co mplete linkage disequilibrium with a single insertion/deletion poly mor-phis m located 5 kb from th e unstable CTG repeat (Imbert et aI199 3) . However, un like th e myotonic dystrophy gene, th e fragile X locus appears to be in linkage equi libriu m with a discrete subset of hap lotypes, which suggests th at multip le mutations of th e pri mordia l FMRl repeat are responsib le for th e fragile X chro moso mes in to day's popu lation (Smits et al 1993) .
A low preva lence of new mutations and marked linkage disequi libriu m suggesting highly ancient mutations are unusual findings for X-linked muta ti ons (Chakravarti 1992) , and this scenario is hard to reconcile in light of the high preva lence of fragile X syndrome in th e popu lation. One possible expla nation for this pheno mena is an unexpectedly high nu mber of pre mutations in th e popu lation th at go undetected in th e absence of any obvious phenotype. In favor of th is hypothesis, Snow et al (199 3) found th e frequency of premuta ti on alle les in th e nor ma l popu lation to be 0.8%. A mu ltistep model has been proposed th at invokes a discrete set of mutations of a nor mal primordial allele to a pre-pre mutation, or a predisposed allele, th at is relati vely stab le for many years (thus accounting for th e linkage disequilibriu m observed ) but has th e potential to convert to unstable premutations th at rapidly expand to fu ll mu tations with concurrent disease expression (Morton & Macpherson 1992) . In light of th is mode l and th e above linkage disequi libriu m data, Oudet et al (199 3 ) asserted th at the most co mmon 30 allele of th e CGG repeat of FMRl (Brown et al 1993, Snow et al 199 3) was probab ly th e pri mordia l allele and that larger alleles in th e range of 38-40 repeats represent th e predisposed alleles th at ulti mately account for all of th e fragile X chro moso mes. In addition, it has been suggested th at a mutation of one of th e interspersed AGG trip lets to CGG within th e nor mally cryptic repeat of FMRl (Pieretti et a1 1991 , Verkerk et a1 1991 could account for th e pri mordial mutation event (Oudet et a1199 3) because repeats th at are purer in content are less stable (Weber 1990 ) . Finally, superimposed upon th is mode l is th e like lihood of polymerase slippage during replication of th ese reiterated sequences (Imbert et al 1993) , which accounts for th e smaller, inert variation in th e nor ma l CGG repeat length contributing to the nor mally polymorphic nature of th e repeats. If th is mode l is valid, th en it follows th at th e primary new mutations responsible for th e cases of fragile X syndrome to day probab ly occurred many generations ago, and any new mutations identified to day may not manifest th emselves phenotypica lly for many years to co me.
The apparent dearth of expansion of premutation alleles into the fu ll muta ti on range upon tr ans mission from carrier males to th eir obligate carrier daugh te rs has also recently been addressed. Upon discovery of a rare mating event by an affected male, Wi l lems et al (1992) followed th e segregation of th e fragile X mutation from an affected male th rough his nor ma l carrier daughter to an affected grandson. At th e mo lecular level, th e daughter received only a premutation allele, whereas th e grandfather was mosaic for fu ll and premuta-tion-size alleles, which suggested a priori that the grandfather displayed germ line mosaicism as well as so matic mosaicism. However, subsequent analyses of affected males with full mutations in so matic tissues revealed only pre muta tion alleles in their sper m (Reyniers et al 1993) . One interpretation of these findings is that partial trinucleotide repeat expansion occurs within the male ga mete, with subsequent selection against sper m with fully expanded repeats. Another interpretation is that trinulceotide repeat expansion occurs postzygoti cally following the sequestering of primordial ger m cells that are spared the massive expansion. However, a maternal imprint must be invoked that leads to so matic expansion of maternal pre mutations. With regard to this model of postzygotic expansion, it will be crucial to determine whether oocytes with full mutations are observed in ovaries of carrier fe males. To date, no such analysis of repeat sizes in oocytes has been reported.
A prediction of such a postzygotic expansion model is that a variable degree of repeat length mosaicis m should be present in the so matic tissues of affected patients. Indeed, so matic mosaicism in cells of fragile X patients has been well documented , Rousseau et al 1991a . In a study of 511 individuals from 63 fragile X fa milies, Rousseau et al (1991b) reported that approxi mately 15 % of individuals with mutations within the fully expanded range also displayed pre mutation alleles in a subset of cells. In individuals such as these, the pre mutation allele is predo minately un methylated and transcriptionally active, whereas the full mutation allele is most often fully methylated and transcriptionally silent . In analysis of a 13 -week male fetus, nearly identical mosaic patterns were observed across all tissues analyzed, and subsequent prolonged cell culture provided no evidence of mitotic instability of the alleles initially present (Wohrle et aI1993) . Inter estingly, chorionic villi obtained at 10 weeks gestation for prenatal diagnoses displayed fully expanded, unmethylated FMRI repeats, thereby deli miting the window for trinucleotide repeat expansion to be fore this time and methylation of expanded repeats to sometime afterwards. Thus, many data support the idea that expansion occurs postconceptionally, and of the two models described, it is the most widely accepted at the present time.
One major shortcoming of the postzygotic model of repeat expansion is its inability to satis factorily account for the strict parental influence observed in fragile X pedigrees. If this model is valid, then an imprinting phenomenon clearly must also occur to account for the absence of repeat expansion in daughters of carrier males. As previously mentioned, Laird (1987) has pro posed that fragile X syndro me results fro m the abnor mal persistence of an imprint due to inco mplete erasure of X-inactivation on the fragile X chromo some in female gametes. Although the observation of abnormal methylation associated with repeat expansion is consistent with this hypothesis, the occur rence of mosaicis m for full and pre mutation alleles and the fact that pre muta-ti on alleles are unmethylated are dif ficult to reconcile with regard to Laird's hypothesis. Further more, corroborating data from tw o labs indicate th at expansion precedes methylation in th e embryo (Sutherland et al 1991 , which makes it questionable whether methylation in any form contributes to th e lack of expansion in daughters of carrier males. So, validation of th e postzygotic model of repeat expansion is incumbent upon identification of th e factor responsible for th e strict maternal origin of expanded FMRI alleles.
CHARACTERIZATION OF FMRl AND THE GENE PRODUCT
Since the identi fication of th e FMRI gene, much has been gleaned with regard to its physical structure and pattern of expression. The FMRI gene includes 17 exons encompassing 38 kb of th e human genome . The eGG repeat resides within th e first exon of th e gene and is positioned 25 0 basepairs downstream of the CpG island th at is aberrantly methylated in fragile X patients and may serve as th e promoter of th e FMRI gene (Hwu et al 1993) . On Northern analysis, expression in a nu mber of human ti ssues both related and unrelated to th e fragile X phenotype is observed; th ese include brain, te stes, placenta, lung, kidney, and heart (Hinds et al 1993 ) . In situ RNA expression studies in adult mouse ti ssues expanded th e list of tissues by adding esophageal epithelium, thymus, spleen, ovary, eye, colon, uterus, th yroid, and liver; expression in heart, aorta, or muscle was not observed in th e adult mouse (Hinds et al 1993 ) . In cross sections of mouse brain, Hinds et al (1993) reported expression predominately in neurons as opposed to white matte r or glial celis, with highest levels of expression in th e cerebellu m, habenula, and th e granular layers of th e hippocampus and cerebral cortex. In a recent in situ RNA expression analysis of cross sections of brain from a 25 -week-old human fetus (Abitbol et a11993), th e authors report FMRI expression mainly in neurons; th e nucleus basalis magnoceliularis and areas of th e hippocampus are most intense. These results are consistent with th e observations by Hinds et al (1993) in th at predominant labeling is observed in areas critical to limbic circuitry, which is a pathway in th e brain involved in cognition, memory, and behavior.
Immunohistochemical analysis with antibodies against FMRP con firmed th e predo minant neuronal and sparse glial distribution of FMRP previously indi cated by in situ RNA studies (Devys et al 1993 ) . In addition, tw o reports of intracellular immunolocalization of FMRP concur th at th e protein is localized predo minately to th e cytosol, although nuclear localization in th e absence of cytosolic expression was observed in a small proportion of cells (Devys et al 1993, Verheij et aI1993). Interestingly, th e amino te rminal half of th e protein displayed exclusive nuclear localization according to Devys et al (1993) , although this half of the protein displays no nuclear localization signal and lacks the putative nuclear localization signal near the carboxy ter minus de scribed by Verkerk et al (1991 ) . Thus, it remains unclear whether FMRP might, under certain conditions, have a functional role in the nucleus.
The mouse FMRI ho mologue has been identified and shown to be re mark ably conserved, with nucleotide and amino acid identity values of 95% and 97%, respectively, within the coding region (Ashley et al 1993a) . The CGG repeat responsible for the fragile X phenotype in humans is also conserved in mouse both in its position and nucleotide sequence, although the repeat nu mber is reduced to nine copies (8 CGGs and 1 CGA) (Ashley et al 1993a ). An in-frame stop codon identified upstream of the human repeat and a conserved A TG located 66 and 69 nucleotides downstream of the CGG repeat in mouse and hu man, respectively, delimit the CGG repeat to the 5' untranslated region (5' UTR) of the FMRI message and predict a putative protein product of 69 kD (Ashley et al 1993a ). Additionally, alternative splicing of the FMRI gene has been docu mented. The results of this splicing predict at least twelve potential isofor ms of the FMRI predicted protein, FMRP, in all tissues ana lyzed and suggest the potential for intracellular functional diversity of the FMRI gene product (Verkerk et al 1993 , Ashley et al 1993a . In favor of the notion of functional heterogeneity is the fact that a subset of the alternative splicing events in FMRI alter the normal reading frame and produce isofor ms with novel carboxy ter mini and quite distinct hydropathy profiles (Ashley et al 1993a) .
Two copies of a 30-a mino acid do main conserved across evolution fro m bacteria to humans have been identified within the amino terminal half of the FMRP predicted sequence (Ashley et al 1993b , Siomi et al 1993b . This repeated do main, termed a KH do main (Siomi et al 1993a ) , is also present in a number of proteins that have an interaction with RNA in co m mon, including one member of the hnRNP class of ribonucleoproteins, hnRNP K. Also iden tified within the carboxy ter minal portion FMRP amino acid sequence are two copies of the RGG box (arginine-glycine-glycine) (Ashley et al 1993b) , an amino acid motif implicated in both RNA as well as DNA binding (Christensen & Fuxa 1988) . Nucleic acid binding assays of in vitro translated FMRP reveal that it is an RNA binding protein that binds to its own RNA transcript with high affinity (Kd = 5.7 nM) and to a lesser extent to a pool of RNAs from human fetal brain; weak binding of FMRP to both single-strand and double strand DNA is observed as well (Ashley et al 1993b) . Selective binding of FMRP to individual human fetal brain transcripts occurs, and it is suggested that approxi mately 4% of the messages present in human fetal brain might be bound by FMRP, which is consistent with the highly pleiotropic nature of the fragile X phenotype (Ashley et al 1993 b) . Finally, a 2: 1 stoichiometry of binding of RNA:protein is reported, which implies that each protein molecule has the potential to interact with two RNA molecules (Ashley et al 1993b) .
CONCLUSIONS
Fragile X syndrome accounts for a major proportion of mental retardation in hu mans. In addition to the intellectual deficit, these patients also exhibit a wide range of behavioral problems, including autistic-like features. Thus, the mo lecular understanding of this syndrome should lead to further understanding of the higher cognitive functioning in hu mans. Indeed, much has already been learned from the cloning of the fragile X gene, FMR1. The mutational basis of the syndro me is the extraordinary expansion of a trinucleotide repeat within the 5' untranslated region of the gene. Since this discovery, six other genetic diseases, all neurological in nature, have now been attributed to unstable triplet repeats within exons of different genes. This novel mutational mechanis m will likely be found responsible for even more genetic disorders. The mechanis m of repeat expansion is poorly understood and is a fertile and important area of inquiry.
When the CGG repeat in the FMRl gene exceeds 23 0 repeats, the gene is heavily methylated and transcriptionally suppressed. The absence of the en coded protein, FMRP, is therefore believed responsible for the mental retar dation and associated phenotype. This cytosolic protein has been de monstrated to be a selective RNA-binding protein, interacting with as much as 4% of human brain mRNA. Thus, the further understanding of this interaction and the identification of those genes whose messages interact could lead to a great deal of insight into the mechanis ms of cognitive function in humans.
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